Difference between revisions of "Machine Learning / Artificial Intelligence"

From PHUSE Wiki
Jump to: navigation, search
(Project Members)
(Project Members)
 
(4 intermediate revisions by 2 users not shown)
Line 40: Line 40:
 
|Anupama Sheoran||Participant||Bayer||Anupama.Sheoran@bayer.com ||Ansari Shaaz || Participant || Gene || Ansari.Shaaz@gene.com
 
|Anupama Sheoran||Participant||Bayer||Anupama.Sheoran@bayer.com ||Ansari Shaaz || Participant || Gene || Ansari.Shaaz@gene.com
 
|-
 
|-
|Akhil Vijayan || Participant || Genpro ||akhil.vijayan@genproindia.com ||  
+
|Akhil Vijayan || Participant || Genpro ||akhil.vijayan@genproindia.com || Amit Jain || Participant || GSK || amit.3.jain@gsk.com
 
|-
 
|-
|Amit Jain || Participant || GSK || amit.3.jain@gsk.com || Aman Bahl || Participant || Syneos Health || aman.bahl@syneoshealth.com
+
|Aman Bahl || Participant || Syneos Health || aman.bahl@syneoshealth.com ||Ashokvardhan Gunuganti||Participant||Pfizer||Ashokvardhan.gunuganti@pfizer.com  
 
|-
 
|-
|Ashokvardhan Gunuganti||Participant||Pfizer||Ashokvardhan.gunuganti@pfizer.com ||Alex Mutuki || Participant || Phastar || alexsincere33@gmail.com
+
|Alex Mutuki || Participant || Phastar || alexsincere33@gmail.com ||Azia Tariq || Participant || GSK || azia.x.tariq@gsk.com
 
|-
 
|-
|Azia Tariq || Participant || GSK || azia.x.tariq@gsk.com||Bhavin Busa || Participant || Vita Data Sciences|| bbusa@softworldinc.com  
+
|Bhavin Busa || Participant || Vita Data Sciences|| bbusa@softworldinc.com || Bhawna Goel || Participant || AstraZeneca || bhawna.goel@astrazeneca.com  
 
|-
 
|-
| Bhawna Goel || Participant || AstraZeneca || bhawna.goel@astrazeneca.com ||Christopher Kuhn || Participant || Syneos Health|| Christopher.Kuhn@syneoshealth.com
+
|Christopher Kuhn || Participant || Syneos Health|| Christopher.Kuhn@syneoshealth.com || Christine Teng||Participant||Merck||Christine_Teng@merck.com
 
|-
 
|-
| Christine Teng||Participant||Merck||Christine_Teng@merck.com || Chintan Pandya || Participant || Merck || Chintan.Pandya@merck.com
+
|Chintan Pandya || Participant || Merck || Chintan.Pandya@merck.com || David Schmeidler || Participant || Regenxbio || dschmeidler@regenxbio.com
 
|-
 
|-
| David Schmeidler || Participant || Regenxbio || dschmeidler@regenxbio.com ||Daryna Hololovich || Participant || Intego || Darina.Hololovich@gmail.com
+
|Daryna Hololovich || Participant || Intego || Darina.Hololovich@gmail.com ||Eric Weising || Participant || Ratilan || eweising@symbiance.com
 
|-
 
|-
|Eric Weising || Participant || Ratilan || eweising@symbiance.com  
+
|Faheeza Rangunwala || Participant || GCE|| gcesolutions.com || Fred Ross || Participant || Quanticate || Fred.Ross@quanticate.com
 
|-
 
|-
| Faheeza Rangunwala || Participant || GCE|| gcesolutions.com ||
+
|Freddie Paino || Participant || Celgene || fpaino@celgene.com || Gary Chen || Participant || Pfizer || Gary.Chen@pfizer.com
 
|-
 
|-
| Fred Ross || Participant || Quanticate || Fred.Ross@quanticate.com||Freddie Paino || Participant || Celgene || fpaino@celgene.com || || ||
+
|Gopal Subrahmanyam || Participant || Emdserono ||Zubrahmanyam.Rajagopal@emdserono.com|| Hui Song || Participant || Prahs || songhui@prahs.com
 
|-
 
|-
| Gary Chen || Participant || Pfizer || Gary.Chen@pfizer.com ||Gopal Subrahmanyam || Participant || Emdserono || Subrahmanyam.Rajagopal@emdserono.com
+
| Hrideep Antony || Participant || Syneos Health || hrideep.antony@syneoshealth.com|| Imran Rashid || Participant || JNJ || Irashid@its.jnj.com
 
|-
 
|-
| Hui Song || Participant || Prahs || songhui@prahs.com || Hrideep Antony || Participant || Syneos Health || hrideep.antony@syneoshealth.com
+
| Jay Gohel || Participant || JNJ || jgohel1@its.jnj.com ||Ingeborg Holt || Participant|| Industry || ingeborgholt@gmail.com
 
|-
 
|-
| Imran Rashid || Participant || JNJ || Irashid@its.jnj.com || Jay Gohel || Participant || JNJ || jgohel1@its.jnj.com
+
| Sangeeta Bhattacharya || Participant || JNJ ||SBhatt11@its.jnj.com|| Jiannan Kang || Participant || Merck || Jiannan_Kang@merck.com
 
|-
 
|-
|Ingeborg Holt || Participant|| Industry || ingeborgholt@gmail.com|| Sangeeta Bhattacharya || Participant || JNJ ||SBhatt11@its.jnj.com
+
|Jacob Mathew || Participant || GCE || Jacob.Mathew@gcesolutions.com || Julia Popova || Participant || Independent|| mogul.mail@gmail.com  
 
|-
 
|-
| Jiannan Kang || Participant || Merck || Jiannan_Kang@merck.com ||Jacob Mathew || Participant || GCE || Jacob.Mathew@gcesolutions.com
+
|Jiangtang Hu || Participant || d-wise || jiangtang.hu@d-wise.com|| Jinesh Shah || Participant || CSLBehring || jinesh.shah@cslbehring.com
 
|-
 
|-
| Julia Popova || Participant || Independent|| mogul.mail@gmail.com ||Jiangtang Hu || Participant || d-wise || jiangtang.hu@d-wise.com
+
|Joyce Leflar || Participant || JNJ || JLeflar@its.jnj.com ||Khyati Patel || Participant || Syneos Health || Khyati.Patel@syneoshealth.com
|-
 
| Jinesh Shah || Participant || CSLBehring || jinesh.shah@cslbehring.com|| |Joyce Leflar || Participant || JNJ || JLeflar@its.jnj.com  
 
|-
 
|Khyati Patel || Participant || Syneos Health || Khyati.Patel@syneoshealth.com
 
 
|-
 
|-
 
| Karl Brand || Participant || Bayer|| Karl.Brand@bayer.com ||Karnika Dalal || Participant || Bayer || Karnika.Dalal@bayer.com
 
| Karl Brand || Participant || Bayer|| Karl.Brand@bayer.com ||Karnika Dalal || Participant || Bayer || Karnika.Dalal@bayer.com
Line 86: Line 82:
 
|Lynn Caldwell || Participant || Pfizer || Lynn.Caldwell@pfizer.com || Sesh Srinizasan || Participant || Deloitte || sesrinivasan@deloitte.com
 
|Lynn Caldwell || Participant || Pfizer || Lynn.Caldwell@pfizer.com || Sesh Srinizasan || Participant || Deloitte || sesrinivasan@deloitte.com
 
|-
 
|-
|Martin Fleming|| Participant || Boehringer-ingelheim || martin.fleming@boehringer-ingelheim.com || |Marko Zivkovic || Participant ||Genesis||  
+
|Martin Fleming|| Participant || Boehringer-ingelheim || martin.fleming@boehringer-ingelheim.com || |Marko Zivkovic || Participant ||Genesis|| marko@genesisrg.com
marko@genesisrg.com
 
 
|-
 
|-
 
|Marek Kajan|| Participant || JNJ ||MKajan@its.jnj.com||Munish Mehra || Participant || Tigermed ||munish.mehra@tigermed.net
 
|Marek Kajan|| Participant || JNJ ||MKajan@its.jnj.com||Munish Mehra || Participant || Tigermed ||munish.mehra@tigermed.net
Line 93: Line 88:
 
| Michael Allie || Participant || Astrazeneca || Michael.Allie1@astrazeneca.com ||Michael Upshall || Participant || Unsilo || michael.upshall@unsilo.com
 
| Michael Allie || Participant || Astrazeneca || Michael.Allie1@astrazeneca.com ||Michael Upshall || Participant || Unsilo || michael.upshall@unsilo.com
 
|-
 
|-
| Mithun Kumar || Participant || Boehringer-ingelheim.com || mithun_kumar.ranga@boehringer-ingelheim.com
+
| Mithun Kumar || Participant || Boehringer-ingelheim.com || mithun_kumar.ranga@boehringer-ingelheim.com|| Mikael Flensborg || Participant || Unsilo || mf@unsilo.com
|-
 
| Mikael Flensborg || Participant || Unsilo || mf@unsilo.com ||Mina Chen || Participant || Roche || Mina.Chen@roche.com
 
 
|-
 
|-
|Nick Burch || Participant || Quanticate || Nick.Burch@quanticate.com ||Paul Slagle || Participant || Inventiv Health || Paul.Slagle@inventivhealth.com  
+
|Mina Chen || Participant || Roche || Mina.Chen@roche.com||Paul Slagle || Participant || Inventiv Health || Paul.Slagle@inventivhealth.com
 
|-
 
|-
 
|Piotr Karasiewicz || Participant || Quanticate || Piotr.Karasiewicz@quanticate.com ||Pratyusha Kajipet || Participant|| Syneos Health||pratyusha.kajipet@syneoshealth.com
 
|Piotr Karasiewicz || Participant || Quanticate || Piotr.Karasiewicz@quanticate.com ||Pratyusha Kajipet || Participant|| Syneos Health||pratyusha.kajipet@syneoshealth.com
 
|-
 
|-
| Prasanna Murugesan || Participant || Independent || prasanna.murugesan@gmail.com || Raj Thota || Participant || Merck || Rajashekar.Thota@merck.com
+
| Prasanna Murugesan || Participant || Independent || prasanna.murugesan@gmail.com|| Phani Ponnapalli|| Participant || Syneoshealth || phani.ponnapalli@syneoshealth.com
|-
 
| Phani Ponnapalli|| Participant || Syneoshealth || phani.ponnapalli@syneoshealth.com ||Russ Lavery || Participant || Verizon || Russ.Lavery@verizon.net
 
 
|-
 
|-
|Priya Gopal || Participant || Industry || priagopal@gmail.com||Robert Michalik || Participant || Regulatory Pro Consulting || rjmichalik@regulatorypro.consulting
+
|Russ Lavery || Participant || Verizon || Russ.Lavery@verizon.net ||Priya Gopal || Participant || Industry || priagopal@gmail.com
 
|-
 
|-
|Richard Phillips || Participant ||Covance || richard.phillips@covance.com || Satheesh Avvaru || Participant || MaxisIT Inc|| avvarusatheesh@gmail.com  
+
| Raj Thota || Participant || Merck || Rajashekar.Thota@merck.com ||Ramesh Naidu Kavicharla || Participant || CRC Pharma || rnaidu.kavicharla@crcpharma.com
 
|-
 
|-
|Sairam Gorthi || Participant || JNJ || sgorthi1@its.jnj.com ||Sagar Jain || Participant || Independent || jainwave@gmail.com  
+
|Robert Michalik || Participant || Regulatory Pro Consulting ||rjmichalik@regulatorypro.consulting||Richard Phillips || Participant ||Covance || richard.phillips@covance.com
 
|-
 
|-
|Santos K Lingala || Participant || Syneos Health || santoshkumar.lingala@syneoshealth.com ||Sarah Bowen || Participant || Quanticate || Sarah.Bowen@quanticate.com  
+
|Satheesh Avvaru || Participant || MaxisIT Inc|| avvarusatheesh@gmail.com||Sairam Gorthi || Participant || JNJ || sgorthi1@its.jnj.com
 
|-
 
|-
|Santosh Tymms || Participant || Quanticate || Santosh.Tymms@quanticate.com ||Sam Tomioka || Participant || Sunovion ||sam.tomioka@sunovion.com
+
|-|Sagar Jain || Participant || Independent || jainwave@gmail.com ||Santos K Lingala || Participant || Syneos Health || santoshkumar.lingala@syneoshealth.com
 
|-
 
|-
|Sudir Singh ||Participant || Nektar Theapeutics || SSingh@nektar.com
+
|Sarah Bowen || Participant || Quanticate || Sarah.Bowen@quanticate.com||Santosh Tymms || Participant || Quanticate || Santosh.Tymms@quanticate.com
 
|-
 
|-
|Sherry Wang || Participant|| GSK || Sherry.3.wang@gsk.com ||Shantanu Nagpal || Participant || Novartis || shantanu.nagpal@novartis.com
+
|Sam Tomioka || Participant || Sunovion ||sam.tomioka@sunovion.com||Sudir Singh ||Participant || Nektar Theapeutics || SSingh@nektar.com
 
|-
 
|-
|Sumeet Uppal||Participant||Boehringer-Ingelheim||Sumeet.uppal@boehringer-ingelheim.com ||Sundar Selvatharasu ||Participant || SierraLabs|| sundar@sierralabs.com
+
|Sherry Wang || Participant|| GSK || Sherry.3.wang@gsk.com||Shantanu Nagpal || Participant || Novartis || shantanu.nagpal@novartis.com
 
|-
 
|-
| Tania Walton || Participant || Independent || Tee_Walton@yahoo.com ||Thomas Kalfas || Participant || Geninvo || thomas.k23@geninvo.com
+
|Sumeet Uppal||Participant||Boehringer-Ingelheim||Sumeet.uppal@boehringer-ingelheim.com||Sundar Selvatharasu ||Participant || SierraLabs|| sundar@sierralabs.com |
 
|-
 
|-
|Tarun Prashanth || Participant || Ratilan || tarun.prashanth@ratilan.com || Tatiana Scetinina || Participant || AstraZeneca || Tatiana.Scetinina@astrazeneca.com
+
| Tania Walton || Participant || Independent || Tee_Walton@yahoo.com||Thomas Kalfas || Participant || Geninvo || thomas.k23@geninvo.com
 
|-
 
|-
| Vishnu Kollisetti || Participant || PPDI || Vishnu.Kollisetti@ppdi.com || Vishnu Alamuri || Participant || Independent || Teja.Alamuri@gmail.com
+
|Tarun Prashanth || Participant || Ratilan || tarun.prashanth@ratilan.com|| Tatiana Scetinina || Participant || AstraZeneca || Tatiana.Scetinina@astrazeneca.com
 
|-
 
|-
| William Wei||Participant||Merck||William.Wei@merck.com ||Vimal Shah||Participant||Parexel||Vimal.Shah@parexel.com
+
| Vishnu Kollisetti || Participant || PPDI || Vishnu.Kollisetti@ppdi.com|| Vishnu Alamuri || Participant || Independent || Teja.Alamuri@gmail.com
 
|-
 
|-
| Vineet Sharma || Participant || Sarepta || Vsharma@sarepta.com ||Walter Cedeno|| Participant ||JNJ || WCEDENO@its.jnj.com
+
| William Wei||Participant||Merck||William.Wei@merck.com||Vimal Shah||Participant||Parexel||Vimal.Shah@parexel.com
 
|-
 
|-
|Yixun Wu || Participant || Syneos Health || yixun.wu@syneoshealth.com ||Yongjiang (Jerry) Xu || Participant || CSL Behring || Yongjiang.Xu@cslbehring.com
+
| Vineet Sharma || Participant || Sarepta || Vsharma@sarepta.com||Walter Cedeno|| Participant ||JNJ || WCEDENO@its.jnj.com
 
|-
 
|-
|Ramesh Naidu || Participant || CRC Pharma || rnaidu.kavicharla@crcpharma.com  
+
|Yixun Wu || Participant || Syneos Health || yixun.wu@syneoshealth.com||Yongjiang (Jerry) Xu || Participant || CSL Behring || Yongjiang.Xu@cslbehring.com
 
|}
 
|}
  

Latest revision as of 05:04, 20 November 2019


Project Overview

The most popular buzz word nowadays in the technology world is 'Machine Learning' (ML) and Artificial Intelligence (AI). Most economists and business experts foresee ML & AI changing every aspect of our lives in the next 10 years through automating and optimizing processes such as self-driving vehicles, online recommendations on Netflix and Amazon, fraud detection in banks, image and video recognition, natural language processing, question answering machines (e.g., IBM Watson) and many more. ML is a game changer and it will also impact the pharmaceutical industry greatly; diagnosis in medical imaging, analysing the deluge of healthcare data, drug discovery, robotic surgery and personalised medicine for example.

This project will explore its application to the pharmaceutical industry. Our goal is first to introduce ML & AI to the pharmaceutical industry. ML & AI are foreign to most programmers and statisticians in the pharmaceutical industry. This project will help them to start ML & AI educations materials. Secondly we will explore how ML & AI can foster innovative approaches in data-driven research and drug development, personalised medicines, faster drug discovery and many more.

The ML/AI project has split into 5 sub-teams

  • Data Collaboration
  • Publication
  • Implementation in Pharmaceutical Industry
  • Projects
    • Tumor Assessment
    • SDTM Mapping
    • Chatbot Development

Project Leads

Name Role Organization E-mail
Kevin Lee Project Co-Lead Clindata Insight kevin.kyosun.lee@gmail.com
Sairam Gorthi Project Co-Lead J&J sgorthi1@its.jnj.com
Lauren White Project Co-ordinator PHUSE Lauren@phuse.eu

Project Members

Name Role Organization E-mail Name Role Organization E-mail
Abhishek Mittal Participant GCE Solutions abhishek.mittal@gcesolutions.com Andy Iverson Participant Medtronic andy.iverson@medtronic.com
Ashwin Participant GSK v.2.ashwin@gsk.com Amardeep Pandey Participant Deloitte amapandey@deloitte.com
Anupama Sheoran Participant Bayer Anupama.Sheoran@bayer.com Ansari Shaaz Participant Gene Ansari.Shaaz@gene.com
Akhil Vijayan Participant Genpro akhil.vijayan@genproindia.com Amit Jain Participant GSK amit.3.jain@gsk.com
Aman Bahl Participant Syneos Health aman.bahl@syneoshealth.com Ashokvardhan Gunuganti Participant Pfizer Ashokvardhan.gunuganti@pfizer.com
Alex Mutuki Participant Phastar alexsincere33@gmail.com Azia Tariq Participant GSK azia.x.tariq@gsk.com
Bhavin Busa Participant Vita Data Sciences bbusa@softworldinc.com Bhawna Goel Participant AstraZeneca bhawna.goel@astrazeneca.com
Christopher Kuhn Participant Syneos Health Christopher.Kuhn@syneoshealth.com Christine Teng Participant Merck Christine_Teng@merck.com
Chintan Pandya Participant Merck Chintan.Pandya@merck.com David Schmeidler Participant Regenxbio dschmeidler@regenxbio.com
Daryna Hololovich Participant Intego Darina.Hololovich@gmail.com Eric Weising Participant Ratilan eweising@symbiance.com
Faheeza Rangunwala Participant GCE gcesolutions.com Fred Ross Participant Quanticate Fred.Ross@quanticate.com
Freddie Paino Participant Celgene fpaino@celgene.com Gary Chen Participant Pfizer Gary.Chen@pfizer.com
Gopal Subrahmanyam Participant Emdserono Zubrahmanyam.Rajagopal@emdserono.com Hui Song Participant Prahs songhui@prahs.com
Hrideep Antony Participant Syneos Health hrideep.antony@syneoshealth.com Imran Rashid Participant JNJ Irashid@its.jnj.com
Jay Gohel Participant JNJ jgohel1@its.jnj.com Ingeborg Holt Participant Industry ingeborgholt@gmail.com
Sangeeta Bhattacharya Participant JNJ SBhatt11@its.jnj.com Jiannan Kang Participant Merck Jiannan_Kang@merck.com
Jacob Mathew Participant GCE Jacob.Mathew@gcesolutions.com Julia Popova Participant Independent mogul.mail@gmail.com
Jiangtang Hu Participant d-wise jiangtang.hu@d-wise.com Jinesh Shah Participant CSLBehring jinesh.shah@cslbehring.com
Joyce Leflar Participant JNJ JLeflar@its.jnj.com Khyati Patel Participant Syneos Health Khyati.Patel@syneoshealth.com
Karl Brand Participant Bayer Karl.Brand@bayer.com Karnika Dalal Participant Bayer Karnika.Dalal@bayer.com
Kathryn Matto Participant IBM kathryn.matto@us.ibm.com Keval Khinchadia Participant Independent kevalk123@yahoo.com
Lorin Miller Participant GCE Solutions Lorin.Miller@gcesolutions.com Li Chen Participant BMS Lu.Chen@bms.com
Lubomir Tarabcak Participant JNJ Utarabak@its.jnj.com Matthew Travell Participant GSK matthew.x.travell@gsk.com
Lynn Caldwell Participant Pfizer Lynn.Caldwell@pfizer.com Sesh Srinizasan Participant Deloitte sesrinivasan@deloitte.com
Martin Fleming Participant Boehringer-ingelheim martin.fleming@boehringer-ingelheim.com Marko Zivkovic Participant Genesis marko@genesisrg.com
Marek Kajan Participant JNJ MKajan@its.jnj.com Munish Mehra Participant Tigermed munish.mehra@tigermed.net
Michael Allie Participant Astrazeneca Michael.Allie1@astrazeneca.com Michael Upshall Participant Unsilo michael.upshall@unsilo.com
Mithun Kumar Participant Boehringer-ingelheim.com mithun_kumar.ranga@boehringer-ingelheim.com Mikael Flensborg Participant Unsilo mf@unsilo.com
Mina Chen Participant Roche Mina.Chen@roche.com Paul Slagle Participant Inventiv Health Paul.Slagle@inventivhealth.com
Piotr Karasiewicz Participant Quanticate Piotr.Karasiewicz@quanticate.com Pratyusha Kajipet Participant Syneos Health pratyusha.kajipet@syneoshealth.com
Prasanna Murugesan Participant Independent prasanna.murugesan@gmail.com Phani Ponnapalli Participant Syneoshealth phani.ponnapalli@syneoshealth.com
Russ Lavery Participant Verizon Russ.Lavery@verizon.net Priya Gopal Participant Industry priagopal@gmail.com
Raj Thota Participant Merck Rajashekar.Thota@merck.com Ramesh Naidu Kavicharla Participant CRC Pharma rnaidu.kavicharla@crcpharma.com
Robert Michalik Participant Regulatory Pro Consulting rjmichalik@regulatorypro.consulting Richard Phillips Participant Covance richard.phillips@covance.com
Satheesh Avvaru Participant MaxisIT Inc avvarusatheesh@gmail.com Sairam Gorthi Participant JNJ sgorthi1@its.jnj.com
Sarah Bowen Participant Quanticate Sarah.Bowen@quanticate.com Santosh Tymms Participant Quanticate Santosh.Tymms@quanticate.com
Sam Tomioka Participant Sunovion sam.tomioka@sunovion.com Sudir Singh Participant Nektar Theapeutics SSingh@nektar.com
Sherry Wang Participant GSK Sherry.3.wang@gsk.com Shantanu Nagpal Participant Novartis shantanu.nagpal@novartis.com
Sumeet Uppal Participant Boehringer-Ingelheim Sumeet.uppal@boehringer-ingelheim.com Sundar Selvatharasu Participant SierraLabs
Tania Walton Participant Independent Tee_Walton@yahoo.com Thomas Kalfas Participant Geninvo thomas.k23@geninvo.com
Tarun Prashanth Participant Ratilan tarun.prashanth@ratilan.com Tatiana Scetinina Participant AstraZeneca Tatiana.Scetinina@astrazeneca.com
Vishnu Kollisetti Participant PPDI Vishnu.Kollisetti@ppdi.com Vishnu Alamuri Participant Independent Teja.Alamuri@gmail.com
William Wei Participant Merck William.Wei@merck.com Vimal Shah Participant Parexel Vimal.Shah@parexel.com
Vineet Sharma Participant Sarepta Vsharma@sarepta.com Walter Cedeno Participant JNJ WCEDENO@its.jnj.com
Yixun Wu Participant Syneos Health yixun.wu@syneoshealth.com Yongjiang (Jerry) Xu Participant CSL Behring Yongjiang.Xu@cslbehring.com

Project Updates

Provide project updates in this section.
Date: Description of Update

Objectives and Timelines

List proposed project deliverables and timelines.

Objective Timeline
Gather Machine Learning & Artificial Intelligence education materials 01.Jun.2018
White Paper on Machine Learning & Artificial Implementation on Pharmaceutical Industry 12.Dec.2018

Project Activities

This section can document project activities or serve as a jumping off point to other pages in the project.

Meeting Minutes


Archived Content